Europe Nuclear Medicine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Europe Nuclear Medicine Market is Segmented by Diagnostics (Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET)), Therapeutics (Alpha Emitters, Beta Emitters, and Brachytherapy), Application (Cardiology, Neurology, Oncology, and Other Applications) and Geography (Germany, UK, France, Italy, Spain, and Rest of Europe). The Report Offers the Value (in USD Million) for the Above Segments.

Europe Nuclear Medicine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe Nuclear Medicine Industry Overview

The Europe Nuclear Medicine market is highly competitive, with the presence of a large number of players. There is high competition among the players in the global nuclear medicine market. Additionally, big players in the pharmaceutical and biotechnology industries are leveraging their huge capital reserves to venture into this market, further increasing the competition. Some of the major players in the market are Advanced Accelerator Applications, Bracco Imaging, Cardinal Health, Curium Pharma, GE Healthcare, Merck KGaA (Sigma-Aldrich), Nordion Inc., and Siemens Healthineers AG.

Europe Nuclear Medicine Market Leaders

  1. Cardinal Health

  2. Curium Pharma

  3. GE Healthcare

  4. Novartis AG (Advanced Accelerator Applications)

  5. Siemens Healthineers AG

  6. *Disclaimer: Major Players sorted in no particular order
Europe Nuclear Medicine Market  Concentration